Stroke Drugs Ref is made and published by
ATIF ELNIL.
AppBrain is an independent app data site and isn't affiliated with ATIF ELNIL.
The app name, icon, screenshots and description belong to ATIF ELNIL and are shown as
published on the App Store.
About Stroke Drugs Ref
Stroke Drugs Ref is a medical app developed by ATIF ELNIL.
User Ratings
The app has no ratings yet.
App Information
Stroke Drugs Ref costs $9.99. The app size is 16.04 MB. The latest version available is 1.0. The last update was on April 1, 2026.
Technical Requirements
The app has a content rating of High Maturity. The app has been available on the App Store since April 2026.
Description by ATIF ELNIL(from the App Store)
IMPORTANT: This app is intended for use by qualified healthcare professionals only. Always seek the advice of a qualified clinician before making any medical or prescribing decisions.
Stroke Drugs Ref is a comprehensive evidence-based stroke pharmacology reference for neurologists, stroke physicians, emergency doctors, nurses and allied health professionals. Built for the stroke unit, emergency department and outpatient clinic.
THROMBOLYSIS Complete alteplase and tenecteplase protocols with dosing calculators: - Alteplase: 0.9 mg/kg IV (max 90mg) - bolus and infusion protocol - Tenecteplase: 0.25 mg/kg IV bolus - AcT trial 2022, now preferred in many centres - Eligibility criteria including wake-up stroke (WAKE-UP trial) and extended window (EXTEND trial) - Absolute and relative contraindications with risk-benefit guidance - Complications: symptomatic ICH reversal protocol, angioedema management
Each subscription will automatically renew 3 days before the expiration date for
the same time period. Subscriptions can be cancelled at any time before the renewal.
